Generic drug products constitute over 80% of the pharmaceutical prescriptions. With generic products, patients usually pay less while receiving the equivalent medicine to an approved brand drug product. Generic medicines cost on average about 85% less than the reference brand drug product. This is the reason why they account for over 90% of prescription medicine but cost less than 20% of total spending in the United States alone.
Whether you are a small pharmaceutical company that needs some support in getting their product faster to the market or an investor who has the desire to get into the pharmaceutical industry but doesn’t have the technical or scientific capabilities to develop a product in a timely manner, we can help. We pride ourselves on providing adaptive, scientifically focused, comprehensive development services at every stage of your drug development journey.
Our scientific teams are experienced in early-stage formulation development of both simple and more complex formulations, phase-appropriate analytical method development and validation, development of product specific stability study and product development summary report.
In as little as 2 weeks from initial consultation, you will be provided with a comprehensive report and consultation meeting with one of our scientists who will outlines a proposed pathway forward for your product development.
We are committed to providing excellence, by utilizing our proprietary scientific methods to develop complex solid oral and alternative dosage forms with high-value, difficult to develop, first-to-file or first-to-market product opportunities. Our development capabilities are industry-leading and span all dosage forms, including complex oral solids, injectables, ophthalmics, liquids, topicals and transdermals.
Our development program includes products across a broad range of therapeutic areas including cardiovascular, central nervous system/pain, oncology, inflammation, anti-infective, dermatology, endocrinology, diabetes, rhinology, urology, and hematology, among others.
Our dedicated and highly skilled team of scientists focuses on developing various dosage forms pertaining to Immediate Release (IR)/ Extended Release (ER) products, powder for suspension, solutions, suspensions, topical dosage forms including creams, ointments, lotions, solutions and development of sterile (ophthalmic & injectable) formulations.